List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  2. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  3. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: SURFACE OPTICS CORP.            Topic: CBD171002

    A program to develop a compact, MLA-based, LWIR hyperspectral imager is proposed. The proposed Hyperspectral Chemical Imaging Sensor(HyCIS) builds upon Surface Optics real-time hyperspectral imaging activities, including our 3D full-motion video spectral imaging (FMV-SI)technology and our MIDIS hyperspectral image processor. Simultaneously sampling 16 or more spectral bands from 8 um to 12 um (MWI ...

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  4. HawkEye MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: SA Photonics, Inc.            Topic: CBD171002

    SA Photonics is please to submit the proposal for the HawkEye compact LWIR hyperspectral imaging system. HawkEye leverages SA Photonicsprevious visible, SWIR, and LWIR programs to result in a compact, hand held, battery operated hyperspectral imager in a low cost designapproach. Furthermore, HawkEye will leverages SA Photonics expertise in warfighter body worn equipment and ground troop personaleq ...

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  5. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: Bodkin Design & Engineering, LLC            Topic: CBD171002

    We propose a snapshot mode hyperspectral imager based on the patented micro machine optical element array.This compact device will provide staring hyperspectral imagery without scanning.Operation in the LWIR will permit identification of chemical warfare agents, and toxic industrial chemicals. Its compact size will permit integration into handheld, vehicle borne or drone mounted instruments.

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  6. Additive Manufacture of Respiratory Protection

    SBC: AKITA INNOVATIONS LLC            Topic: CBD181001

    In the proposed SBIR project Akita Innovations and Adaptive 3D will develop feedstock materials and methods for the additive manufacture of soft elastomers that exhibit resistance to the permeation of chemical agents.The goal of the effort is to produce a fully functional Air Purifying Respirator (APR) and to demonstrate advantages of additive manufacturing to provide innovations such as custom si ...

    SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  7. Dermal Medical Countermeasures for Chemical Weapons Exposure

    SBC: Nano Terra, Inc.            Topic: CBD161003

    Chemical warfare agents (CWAs), such as nerve agents and mustard agents, pose serious threats to our warfighters and civilians. Current formulations of dermal medical countermeasures to CWAs can be absorbed through the skin causing systemic toxicities to the patients. These formulations are limited by the FDA for use only in small area of intact skin. This severely restricts the usefulness of thes ...

    SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  8. Detection of Liquid Contaminants on Surfaces Using Hyperspectral Imaging

    SBC: SA Photonics, Inc.            Topic: CBD12104

    SA Photonics is pleased to propose the development of the SENTRY hyperspectral situational awareness system for the detection of liquid chemical agents in the asymmetric terrorist warfare scenario. SA Photonics will be teaming with world renowned experts from its university partners for the development of the SENTRY system. Additionally, SA Photonics will be leveraging technology from numerous N ...

    SBIR Phase II 2014 Department of DefenseOffice for Chemical and Biological Defense
  9. Advanced LWIR Hyperspectral System for On-the-Move Standoff Detection of Liquid and Solid Contaminants on Surfaces

    SBC: Physical Sciences Inc.            Topic: CBD12104

    Physical Sciences Inc. (PSI) proposes to utilize an innovative LWIR hyperspectral technology coupled with advanced data processing algorithms for non-contact, standoff detection of liquid/solid contaminants on surfaces. The technology will address the US Army"s need for fast, on-the-move, non-contact detection of ground contamination during reconnaissance missions. The Phase I effort demonstrated ...

    SBIR Phase II 2014 Department of DefenseOffice for Chemical and Biological Defense
  10. Enhancing the Pharmacokinetic Profile of Protein-based Drugs

    SBC: Extend Biosciences Inc.            Topic: CBD12101

    Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability. Extend Biosciences is developing proprietary carrier molecules that allow proteins to access an intrinsic transport pathway for efficient delivery to the vascular space and then maintain a sustained presence in circulation. This novel technology would be of partic ...

    SBIR Phase II 2014 Department of DefenseOffice for Chemical and Biological Defense

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government